Drug Profile
Research programme: small molecule therapeutics - Taiho/Pharmacopeia Drug Discovery
Alternative Names: Small molecule therapeutics research programme - Taiho/Pharmacopeia Drug DiscoveryLatest Information Update: 05 Jun 2007
Price :
$50
*
At a glance
- Originator Pharmacopeia Drug Discovery; Taiho Pharmaceutical
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 06 May 2004 Pharmacopeia has divided into Pharmacopeia Drug Discovery and Accelrys
- 04 Feb 2004 Preclinical trials in Undefined in Japan (unspecified route)